View Author
study buccal purity sample dna purity collection buccal cell samples blood patient fluence determinant reference leukemia antihypertensive buccal cells laboratory diuretic aml-m buccal swabs myeloid leukemia blood cell count signi ficantly fluence dna antihypertensive drugs treatment protocol epidemiol method difference women signi infant dna samples anthracycline aml-m 6 table participant storage j clin epidemiol count wieren-de buccal cell dna mouthwash 50 ml tube van wieren-de wijer wijer erythroleukemia hyposalivation maastricht cotton swabs transport time netherland myeloid amount ficantly report 1.95 procedure 109/ number genotyping transport pharmo ratio blast full-dose aml treatment diuretic drug users phase buffer reference value maitland-van der zee aml protocol full-term age fi rst case population genomic dna technician aml-mrc -12 protocol research institute maastricht van den heuvel-eibrink
2 Most Recent Publications
|
Determinants of DNA yield and purity collected with buccal cell samples
(Article)
Wieren-de Wijer, D.B.M.A. van Maitland-van der Zee, A-H. Stricker, B.H.Ch. Boer, A. de Belitser, S.V. Kroon, A.A. Leeuw, P.W. de Schiffers, P. Klungel, O.H. Janssen. R.G.J.H. Tikka-Kleemola, P. |
2009-11-01
|
|
Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant
(Article)
Dongen, J.C.A. van Dalinghaus, M. Kroon, A.A. Vries, A.C. de Heuvel-Eibrink, M.M. van den |
2009-11-01
|